Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Revenue (2024 - 2025)

Beta Bionics (BBNX) has disclosed Revenue for 2 consecutive years, with $32.1 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 57.15% to $32.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $100.3 million through Dec 2025, up 53.94% year-over-year, with the annual reading at $100.3 million for FY2025, 53.94% up from the prior year.
  • Revenue hit $32.1 million in Q4 2025 for Beta Bionics, up from $27.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $32.1 million in Q4 2025 to a low of $12.9 million in Q1 2024.